484 related articles for article (PubMed ID: 10914849)
1. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
Wolfe F; Hawley DJ
J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
[TBL] [Abstract][Full Text] [Related]
2. The importance of gastrointestinal (GI) symptom severity in rheumatoid and osteoarthritis: symptom rates and risk for GI hospitalization.
Wolfe F
J Rheumatol; 2000 Jul; 27(7):1661-7. PubMed ID: 10914848
[TBL] [Abstract][Full Text] [Related]
3. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
Fries JF; Bruce B
J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study.
Singh G; Ramey DR; Morfeld D; Shi H; Hatoum HT; Fries JF
Arch Intern Med; 1996 Jul; 156(14):1530-6. PubMed ID: 8687261
[TBL] [Abstract][Full Text] [Related]
5. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
6. The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors.
Benito-Garcia E; Michaud K; Wolfe F
J Rheumatol; 2007 Aug; 34(8):1765-9. PubMed ID: 17611980
[TBL] [Abstract][Full Text] [Related]
7. Predicting the risk of gastrointestinal bleeding due to nonsteroidal antiinflammatory drugs: NSAID electronic assessment of risk.
Cheetham TC; Levy G; Spence M
J Rheumatol; 2003 Oct; 30(10):2241-4. PubMed ID: 14528523
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients at risk for gastropathy associated with NSAID use.
Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
J Rheumatol Suppl; 1990 Feb; 20():12-9. PubMed ID: 2325051
[TBL] [Abstract][Full Text] [Related]
10. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
[TBL] [Abstract][Full Text] [Related]
11. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C
Gastroenterology; 2003 Feb; 124(2):288-92. PubMed ID: 12557133
[TBL] [Abstract][Full Text] [Related]
12. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
13. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
[TBL] [Abstract][Full Text] [Related]
14. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
[TBL] [Abstract][Full Text] [Related]
15. Trends in hospitalizations for gastrointestinal bleeding among patients with rheumatoid arthritis in Rochester, Minnesota, 1950-1991.
Matteson EL; Yachyshyn V; Yachyshyn J; O'Fallon WM
J Rheumatol; 1995 Aug; 22(8):1471-7. PubMed ID: 7473468
[TBL] [Abstract][Full Text] [Related]
16. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
17. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
Cibere J; Sibley JT; Haga M
J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
[TBL] [Abstract][Full Text] [Related]
18. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: how physicians manage treatment failures.
Spencer-Green G; Spencer-Green E
J Rheumatol; 1998 Nov; 25(11):2088-93. PubMed ID: 9818649
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal symptoms and health related quality of life in patients with arthritis.
Wolfe F; Kong SX; Watson DJ
J Rheumatol; 2000 Jun; 27(6):1373-8. PubMed ID: 10852256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
